SCHEMBL3790341

SCHEMBL3790341

CCOc1cc(N)ccc1-c1cccc(N)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
KDM4E B2RXH2 4/20 0.51
GAA P10253 2/20 0.51
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP19A1 P11511 1/20 0.45
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
PTPRC P08575 1/20 0.44
MAP4K4 O95819 2/20 0.44
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FYN P06241 1/20 0.42
MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783390 0.88 MAPT (0.53) MAPTKDM4EGAATP53CYP3A4
SCHEMBL3789274 0.87 KDM4E (0.51) MAPTKDM4EGAATP53CYP3A4
SCHEMBL3793105 0.87 PTPRC (0.55) MAPTKDM4EGAATP53CYP3A4
SCHEMBL30427138 0.84 MAPT (0.56) MAPTKDM4EGAATP53CYP3A4
SCHEMBL2210399 0.84 MAPT (0.56) MAPTKDM4EGAATP53CYP3A4
SCHEMBL347279 0.84 MAPT (0.63) MAPTKDM4EGAATP53CYP3A4
SCHEMBL3787533 0.82 TP53 (0.50) MAPTKDM4EGAATP53CYP3A4
SCHEMBL3792045 0.81 CYP3A4 (0.58) MAPTKDM4EGAACYP3A4CYP19A1
SCHEMBL3792827 0.80 CYP19A1 (0.69) MAPTGAACYP19A1CYP11B1CYP11B2
SCHEMBL3789833 0.78 TP53 (0.62) MAPTKDM4EGAATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885KDM4E 2606/4885GAA 1755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.